Anticancer research · 2025
Ifosfamide-induced Catatonia - A Rare Presentation and Review of Ifosfamide-induced Central Nervous System Toxicity Along With Therapeutic Approaches.
СтатьяКлинический случайОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lyndon Stanley
Аннотация
BACKGROUND/AIM: Ifosfamide is a well-known chemotherapeutic agent used to treat various cancer types but is associated with central nervous system toxicity, termed ifosfamide-induced encephalopathy (IIE). Rarely, this toxicity manifests as catatonia.
CASE REPORT: We present the case of a 61-year-old woman with diffuse large B-cell lymphoma who developed profound catatonia after ifosfamide infusion. Her symptoms resolved completely following a single intravenous dose of lorazepam.
CONCLUSION: This case underscores the importance of recognizing catatonia as a manifestation of IIE and supports the use of lorazepam as both a diagnostic and therapeutic intervention.
CASE REPORT: We present the case of a 61-year-old woman with diffuse large B-cell lymphoma who developed profound catatonia after ifosfamide infusion. Her symptoms resolved completely following a single intravenous dose of lorazepam.
CONCLUSION: This case underscores the importance of recognizing catatonia as a manifestation of IIE and supports the use of lorazepam as both a diagnostic and therapeutic intervention.